COLL · Healthcare · $708M
$21.82-1.84%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 60 Drug Manufacturers - Specialty & Generic peers
Quarterly Revenue Growth
“조나페PM 매출이 4610만 달러로 전년 대비 41% 성장했고 처방 건수도 13.1% 늘며 사상 최고 처방의사 수를 기록했어요.”
In the company's words · 2026 2분기 earnings call